Neogen Corporation reported a 7% increase in revenue for the second quarter of fiscal year 2021, reaching $115 million. The animal safety segment saw a significant 13% increase in sales. Net income decreased slightly to $15.885 million, or $0.30 per share, compared to $16.276 million, or $0.31 per share, in the prior year, impacted by strategic consulting expenses.
Total revenue increased by 7% compared to the previous year's second quarter, reaching $115 million.
Animal Safety segment experienced a strong 13% sales increase, driven by demand for cleaners, disinfectants, and rodenticides.
Food Safety segment revenue increased by 1%, with growth in Soleris microbial testing system and Listeria Right Now test system offset by COVID-19 related disruptions.
Operating income increased to $19.245 million, or 16.7% of sales, compared to $18.272 million, or 16.9% of sales, in the prior year.
Neogen did not provide specific forward guidance in the provided text. The company is seeing signs of recovery with new product launches and strong sales increases in countries less affected by COVID-19.
Visualization of income flow from segment revenue to net income